Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
Saudi Pharmaceutical Journal · 2023-11 · 31 (11) · 101822
DOI: 10.1016/j.jsps.2023.101822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-11. Verfasst von Bander Balkhi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Background
Recently, there has been an increase in the incidence of colorectal cancer in Saudi Arabia. Although numerous studies worldwide have investigated the economic burden of colorectal cancer the information specific to Saudi Arabia remains limited. While advanced cancer treatments offer substantial benefits, they they also come with substantial financial challenges.
Objective
This study aimed to estimate the economic burden of colorectal cancer and identify the primary cost drivers.
Method
This retrospective, single-center cost of illness study examined all patients with colorectal cancer from January 2017 to December 2020. This study used a micro-costing, bottom-up approach to estimate healthcare resource utilization and direct medical costs associated with colorectal cancer.
Result
The study included 326 patients with colorectal cancer. The total direct medical cost for all patients were $19 million, with an annual cost per patient of $58,384. Medication costs were the primary driver of healthcare spending (45%) of the total cost, followed by surgical costs (27%). This study explained cost associated with colorectal cancer, which represents a significant cost to the Saudi healthcare budget. The expected growth and aging of the population and availability of costly treatments may lead to an increase in costs. These findings are valuable for healthcare policymakers seeking to comprehend the economic challenges posed by colorectal cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Surgery, College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia.
Förderung
- King Saud University
Zitieren
APA
Balkhi, B., Alghamdi, A., Alqahtani, S., Al Najjar, M., Al Harbi, A., & Bin Traiki, T. (2023). Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia. Saudi Pharmaceutical Journal, 31(11), 101822. https://doi.org/10.1016/j.jsps.2023.101822
Vancouver
Balkhi B, Alghamdi A, Alqahtani S, Al Najjar M, Al Harbi A, Bin Traiki T. Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia. Saudi Pharmaceutical Journal. 2023;31(11):101822. doi:10.1016/j.jsps.2023.101822
BibTeX
@article{Balkhi2023,
author = {Balkhi, Bander and Alghamdi, Ahmed and Alqahtani, Saeed and Al Najjar, Marwan and Al Harbi, Abdullah and Bin Traiki, Thamer},
title = {Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia},
journal = {Saudi Pharmaceutical Journal},
year = {2023},
volume = {31},
number = {11},
pages = {101822},
doi = {10.1016/j.jsps.2023.101822}
}
EUVIMED